StimCardio's NeuroPulse Study Highlights Significant Drop in Atrial Fibrillation Events Using Wearable Neuromodulation Following Ablation

90% freedom from atrial arrhythmias at six months with neuromodulation vs. 80.8% with shamRandomized, double-blind, sham-controlled results presented as late-breaking clinical science at HRX Live 2026 and simultaneously published in peer-reviewed Heart Rhythm